98%
921
2 minutes
20
NASA's New Horizons mission unveiled a diverse landscape of Pluto's surface with massive regions being neutral in color, while others like Cthulhu Macula range from golden-yellow to reddish comprising up to half of Pluto's carbon budget. Here, we demonstrate in laboratory experiments merged with electronic structure calculations that the photolysis of solid acetylene - the most abundant precipitate on Pluto's surface - by low energy ultraviolet photons efficiently synthesizes benzene and polycyclic aromatic hydrocarbons excited state photochemistry thus providing critical molecular building blocks for the colored surface material. Since low energy photons deliver doses to Pluto's surface exceeding those from cosmic rays by six orders of magnitude, these processes may significantly contribute to the coloration of Pluto's surface and of hydrocarbon-covered surfaces of Solar System bodies such as Triton in general. This discovery critically enhances our perception of the distribution of aromatic molecules and carbon throughout our Solar System.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1039/d1cp04959c | DOI Listing |
Int J Pharm
April 2025
Department of Pharmacy, College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea; Institute of Pharmaceutical Science and Technology, Ajou University, Suwon 16499, Republic of Korea. Electronic address:
Decitabine (DCB) is very unstable in aqueous solutions because of the opening of the N-5 and C-6 aza-ring. The objective of this study was to investigate a stabilization mechanism of aqueous-labile decitabine (DCB) with three different materials by preparing binary spray dried powders (SDs): self-assembling fattigated gelatin-oleic acid conjugate (GOC), micellar polyethylene glycol hexadecyl ether (Brij® 58), nonionic surfactant and electrostatically interactive xanthan gum (XA), an anionic polysaccharide. GOC was synthesized by covalently conjugating oleic acid with gelatin.
View Article and Find Full Text PDFInt J Pharm
March 2025
Department of Pharmacy, College of Pharmacy, Ajou University, Suwon 16499, Republic of Korea; Institute of Pharmaceutical Science and Technology, Ajou University, Suwon 16499, Republic of Korea. Electronic address:
The aim of this study was to investigate the long-term controlled release of peptide-loaded fattigated albumin nanoparticles via calcium ion-triggering nanoaggregation with minimal initial burst release. Fattigated albumin nanoparticles were prepared via sonication by the self-assembly of human serum albumin (HSA)-oleic acid conjugates (AOC) with three different substitution ratios of oleic acid (OA) to modulate hydrophobicity. Then, pasireotide pamoate (PAS) as a model peptide was encapsulated into the hydrophobic core of HSA-OA nanoparticles (PAS-AONs).
View Article and Find Full Text PDFNat Commun
October 2024
Association of Universities for Research in Astronomy, Washington, DC, USA.
Proc Natl Acad Sci U S A
August 2024
Laboratoire d'Études Spatiales et d'Instrumentation en Astrophysique, Observatoire de Paris, Université Paris Sciences & Lettres, CNRS, Sorbonne Université, University of Paris Diderot, Sorbonne Paris Cité, Meudon 92195, France.
Triton and Pluto are believed to share a common origin, both forming initially in the Kuiper Belt but Triton being later captured by Neptune. Both objects display similar sizes, densities, and atmospheric and surface ice composition, with the presence of volatile ices N, CH, and CO. Yet their appearance, including their surface albedo and ice distribution strongly differ.
View Article and Find Full Text PDFCell
August 2024
Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA; Tumor Microenvironment Center, UPMC Hillman Cancer Center, Pittsburgh, PA, USA; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center, Pittsburgh, PA, USA. Electronic address:
Overcoming immune-mediated resistance to PD-1 blockade remains a major clinical challenge. Enhanced efficacy has been demonstrated in melanoma patients with combined nivolumab (anti-PD-1) and relatlimab (anti-LAG-3) treatment, the first in its class to be FDA approved. However, how these two inhibitory receptors synergize to hinder anti-tumor immunity remains unknown.
View Article and Find Full Text PDF